PfizerForAll aims to help improve health care by offering telehealth services, prescription services, vaccination scheduling, ...
The disease-modifying treatment landscape has expanded in recent years, but access to the latest approved Duchenne muscular ...
Findings from an Italian cohort suggest that nusinersen may benefit fatigue measures in patients with spinal muscular atrophy ...
Eli Lilly has introduced discounted single-dose vials of tirzepatide (Zepbound) for self-pay patients with obesity to ...
A phase 2b clinical trial demonstrates the potential of zasocitinib in achieving biologic-level efficacy with minimal adverse ...
The closures highlight financial challenges that rural hospitals face amid workforce shortages, rising costs, and leveling ...
This series was supported by Salix Pharmaceuticals.
Several years of preliminary research results suggest chimeric antigen receptor (CAR) T-cell therapy could benefit pediatric ...
Findings from a post hoc analysis of 3 clinical trials support the switching to or initiation of pegcetacoplan to manage ...
Early-stage detection of colorectal cancer (CRC) could be achieved using a noninvasive multiomics liquid biopsy test, ...
Not all patients will want to take triplet therapy, but those with high-volume prostate cancer who are chemotherapy eligible are usually a good fit, explained Neal D. Shore, MD, FACS. For patients ...
Katherine Baker, MD, MMHC, of Tennessee Oncology, highlights the need for physician-payer collaboration to tackle challenges and drive innovation in specialty care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback